Ferroportin and hepcidin: a new hope in diagnosis, prognosis, and therapy for breast cancer

Breast cancer is the most prevalent malignancy in women. The success of breast cancer treatment relies on the ability to detect the disease and correct molecular abnormalities at an early stage of disease development. A recent article describes a marked decrease in the levels of ferroportin in breast cancer. More importantly, the presented results demonstrate convincingly the incredible diagnostic and prognostic value of ferroportin and hepcidin gene expression in breast cancer and suggest that determination of these two molecular markers may be used as guidance toward individualized therapy for breast cancer patients.

[1]  D. Gilot,et al.  C/EBPα Regulates Hepatic Transcription of Hepcidin, an Antimicrobial Peptide and Regulator of Iron Metabolism , 2002, The Journal of Biological Chemistry.

[2]  O. Kovalchuk,et al.  Role of ferritin alterations in human breast cancer cells , 2011, Breast Cancer Research and Treatment.

[3]  Matthias W. Hentze,et al.  Two to Tango: Regulation of Mammalian Iron Metabolism , 2010, Cell.

[4]  M. Willingham,et al.  Ferroportin and iron regulation in breast cancer progression and prognosis. , 2010, Science translational medicine.

[5]  D. Richardson,et al.  The iron metabolism of neoplastic cells: alterations that facilitate proliferation? , 2002, Critical reviews in oncology/hematology.

[6]  R. Elliott,et al.  Manipulation of iron transporter genes results in the suppression of human and mouse mammary adenocarcinomas. , 2010, Anticancer research.

[7]  G. Lippi,et al.  Hepcidin and iron metabolism: from laboratory to clinical implications. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[8]  D. Gilot,et al.  C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism. , 2002, The Journal of biological chemistry.

[9]  T. Rohan,et al.  Does excess iron play a role in breast carcinogenesis? an unresolved hypothesis , 2007, Cancer Causes & Control.

[10]  Xi Huang.  Does iron have a role in breast cancer? , 2008, The Lancet. Oncology.

[11]  D. Richardson,et al.  Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents. , 2009, Biochimica et biophysica acta.

[12]  J. Liehr,et al.  Role of iron in estrogen-induced cancer. , 2001, Current medicinal chemistry.

[13]  A. Satoskar,et al.  Role of STAT1, NF‐κB, and C/EBPβ in the macrophage transcriptional regulation of hepcidin by mycobacterial infection and IFN‐γ , 2009, Journal of leukocyte biology.

[14]  D. Richardson,et al.  The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. , 1997, Biochimica et biophysica acta.

[15]  M. Fleming.  The regulation of hepcidin and its effects on systemic and cellular iron metabolism. , 2008, Hematology. American Society of Hematology. Education Program.